BEST-CLI试验研究者对均势的態度及实践模式调查
2022年对1180名BEST-CLI研究者进行60题电子调查,在试验结论得出后、结果公布前评估其对慢性肢体威胁性缺血(CLTI)的治疗偏好。应答率20.2%,多数为血管外科医生。治疗模式差异大,多数对先进开放和腔内技术均有经验。与2010年调查相比,血管外科医生总体均势相似,仅在大面积组织缺损的均势比例下降、小面积组织缺损选择腔内治疗比例增加。
要点
- 多数研究者对开放和腔内技术均有经验,但CLTI治疗模式差异大。
- 仅25.8%常规使用WIfI标准,8.3%使用GLASS,14.8%使用风险计算器。
- 89.1%认为CLTI团队改善医疗,但仅23.2%有明确团队。
核心结论
- 血管专科医生治疗CLTI的实践模式差异很大。
- BEST-CLI多数研究者对先进开放和腔内技术均有经验,代表真实世界技术专长样本。
- 在BEST-CLI试验十年间,血管外科医生总体均势相似。
研究设计与样本
- 2022年向1180名BEST-CLI研究者发送60题电子调查,在试验结论得出后、结果公布前进行。
- 应答率20.2%,其中血管外科医生76.3%、介入心脏病医生11.4%、介入放射医生11.6%。
- 多数(72.6%)在学术机构执业,39.1%执业超过20年。
- 将血管外科医生的手术和腔内偏好与2010年试验资助前对前瞻性研究者进行的调查比较。
主要发现
- 初次CLTI评估中,65.8%总是或通常行动脉双功超声,42.6%行CT血管造影,55.9%行静脉标测。
- 腔内与开放手术最常见分布为70/30。
- 术后常规双功监测:静脉旁路99%、人工血管旁路81.9%、腔内干预86%。
- 分别有25.8%、8.3%、14.8%总是或通常使用WIfI标准、GLASS和风险计算器。
- 52.9%认为「腔内优先不烧桥」说法错误;30.1%、18.0%、45.9%分别受手术室或腔内室可用性、个人日程、个人技能影响。
关键数值与推荐
- 88.1%常规使用紫杉醇涂层球囊,67.5%常规使用紫杉醇涂层支架;73.3%在安全担忧提出后改变实践。
- 外科医生中,17.8%每年>10例替代自体静脉旁路,2.9%每年>10例复合静脉旁路,10.3%每年>10例至足部靶血管旁路。
- 介入医生中,8%每年>10例桡动脉入路,24%每年>10例足部或胫动脉入路,8%每年>10例足部环路血运重建。
- 与2010年调查相比,基于TASC II分类或导管偏好无变化;2022年腘动脉闭塞更偏好开放手术。
- 大面积组织缺损的均势比例下降(43.8% vs 31.2%),小面积组织缺损选择腔内治疗增加(17.6% vs 30.8%)(P < .05)。
临床怎么用
- 多数研究者报告对开放和腔内技术均有经验,但治疗模式差异大。
- 多数研究者认为CLTI团队改善医疗,但仅少数有明确团队。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There has been significant variability in practice patterns and equipoise regarding treatment approach for chronic limb-threatening ischemia (CLTI). We aimed to assess treatment preferences of Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) investigators prior to and following the trial. METHODS: An electronic 60-question survey was sent to 1180 BEST-CLI investigators in 2022, after trial conclusion and before announcement of results. Investigators' preferences were assessed across clinical scenarios for both open (OPEN) and endovascular (ENDO) revascularization strategies. Vascular surgeon (VS) surgical and ENDO preferences were compared with a 2010 survey administered to prospective investigators before trial funding. RESULTS: For the 2022 survey, the response rate was 20.2% and was comprised of VSs (76.3%), interventional cardiologists (11.4%) and interventional radiologists (11.6%). The majority (72.6%) were in academic practice and 39.1% were in practice for >20 years. During initial CLTI work-up, 65.8%, 42.6%, and 55.9% of respondents always or usually ordered an arterial duplex, computed tomography angiography, and vein mapping, respectively. The most common practice distribution between ENDO and OPEN procedures was 70/30. Postoperatively, a majority reported performing routine duplex surveillance of vein bypass (99%), prosthetic bypass (81.9%), and ENDO interventions (86%). A minority reported always or usually using the wound, ischemia, and foot infection (WIfI) criteria (25.8%), GLASS (8.3%), and a risk calculator (14.8%). More than one-half (52.9%) agreed that the statement "no bridges are burned with an ENDO-first approach" was false. Intervention choice was influenced by availability of the operating room or ENDO suite, personal schedule, and personal skill set in 30.1%, 18.0%, and 45.9% of respondents, respectively. Most respondents reported routinely using paclitaxel-coated balloons (88.1%) and stents (67.5%); however, 73.3% altered practice when safety concerns were raised. Among surgeons, 17.8%, 2.9%, and 10.3% reported performing >10 annual alternative autogenous vein bypasses, composite vein composite vein bypasses, and bypasses to pedal targets, respectively. Among all interventionalists, 8%, 24%, and 8% reported performing >10 annual radial access procedures, pedal or tibial access procedures, and pedal loop revascularizations. The majority (89.1%) of respondents felt that CLTI teams improved care; however, only 23.2% had a defined team. The effectiveness of the teamwork at institutions was characterized as highly effective in 42.5%. When comparing responses by VSs to the 2010 survey, there were no changes in preferred treatment based on Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) II classification or conduit preference. In 2022, OPEN surgery was preferred more for a popliteal occlusion. For clinical scenarios, there were no differences except a decreased proportion of respondents who felt there was equipoise for major tissue loss for major tissue loss (43.8% vs 31.2%) and increased ENDO choice for minor tissue loss (17.6% vs 30.8%) (P < .05). CONCLUSIONS: There is a wide range of practice patterns among vascular specialists treating CLTI. The majority of investigators in BEST-CLI had experience in both advanced OPEN and ENDO techniques and represent a real-world sample of technical expertise. Over the course of the decade of the BEST-CLI trial, there was overall similar equipoise among VSs.
引用
- Farber A, Siracuse JJ, Giles K, et al. Investigator attitudes on equipoise and practice patterns in the BEST-CLI trial. J Vasc Surg. 2023. PMID: 38056700. doi:10.1016/j.jvs.2023.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。